These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3937071)

  • 1. [Controlled clinical study on the therapeutic efficacy of Enterococcus acidogenus HS 15 of human origin in diarrheic enterocolitis].
    Maggi CA; Corigliano P
    Minerva Dietol Gastroenterol; 1985; 31(4):603-8. PubMed ID: 3937071
    [No Abstract]   [Full Text] [Related]  

  • 2. [Double-blind controlled study of the effect of the lactogenic enterococcus SF68 strain on various enterocolitis associated manifestations and on salmonella infections].
    Bruno F; Nastasi A; Bruno M
    Clin Ter; 1983 May; 105(3):203-7. PubMed ID: 6349913
    [No Abstract]   [Full Text] [Related]  

  • 3. [A new therapeutic alternative for the treatment of enteritis--controlled double-blind tests with the strain SF 68].
    Bruno F; Frigerio G
    Schweiz Rundsch Med Prax; 1981 Sep; 70(39):1717-20. PubMed ID: 6792618
    [No Abstract]   [Full Text] [Related]  

  • 4. [Human colostrum in the prevention of diarrhea and necrotizing enterocolitis].
    Jasso Gutiérrez L; Olivos Fernández V
    Bol Med Hosp Infant Mex; 1980; 37(1):23-30. PubMed ID: 7352966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of enterocolitis and other intestinal disorders with a Bifidobacterium bifidum and Lactobacillus acidophilus combination].
    Satta A; Delplano A; Cossu P; Cossellu S
    Clin Ter; 1980 Jul; 94(2):173-84. PubMed ID: 6778648
    [No Abstract]   [Full Text] [Related]  

  • 6. [A new therapy against the endogenous factor of periodontosis].
    Ebner N
    Osterr Z Stomatol; 1972 Jan; 69(1):24-9. PubMed ID: 4623170
    [No Abstract]   [Full Text] [Related]  

  • 7. [The use of Lactobacillus preparations in clinical practice].
    Pinter EJ
    Union Med Can; 1968 Jan; 97(1):72-3. PubMed ID: 5652328
    [No Abstract]   [Full Text] [Related]  

  • 8. Biologicals and biological response modifiers: design of clinical trials.
    Oldham RK
    J Biol Response Mod; 1985 Apr; 4(2):117-28. PubMed ID: 3889226
    [No Abstract]   [Full Text] [Related]  

  • 9. [Natural products in clinical trials: antiparasitic, antiviral and neurological drugs].
    Zheng D; Han L; Huang XS; Yu SS; Liang XT
    Yao Xue Xue Bao; 2007 Jun; 42(6):576-82. PubMed ID: 17702391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Lactococcus garvieae, Lactococcus lactis and Enterococcus faecalis on the behaviour of Staphylococcus aureus in microfiltered milk.
    Alomar J; Loubiere P; Delbes C; Nouaille S; Montel MC
    Food Microbiol; 2008 May; 25(3):502-8. PubMed ID: 18355675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial characterization of bacteriocins produced by human Lactococcus lactis and Pediococccus acidilactici isolates.
    Millette M; Dupont C; Archambault D; Lacroix M
    J Appl Microbiol; 2007 Jan; 102(1):274-82. PubMed ID: 17184344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating biologic agents in rheumatoid arthritis: a framework for clinical trials.
    Strand V; Scott DL; Panayi GS
    J Rheumatol; 1994 Aug; 21(8):1390-2. PubMed ID: 7983635
    [No Abstract]   [Full Text] [Related]  

  • 13. Are there special considerations relevant to trials of biologic agents?
    Strand V
    J Rheumatol Suppl; 1994 Sep; 41():41-5; discussion 45-9. PubMed ID: 7799384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical research on a biological preparation with stimulating effect on the adrenocortical secretion].
    Mascaretti L
    Minerva Med; 1973; 64(45):2365-70. PubMed ID: 4582182
    [No Abstract]   [Full Text] [Related]  

  • 15. PASI 75.
    Rapaport MJ
    J Am Acad Dermatol; 2005 Jan; 52(1):183-4; author reply 184-5. PubMed ID: 15627120
    [No Abstract]   [Full Text] [Related]  

  • 16. [Possibilities and therapeutic limits of a biological preparation in arthro-neuralgias based on arthrosis].
    Monteleone M
    Clin Ortop; 1973; 24(3):194-201. PubMed ID: 4619063
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of a biological preparation in the treatment of cervicobrachialgia and lumbosciatalgia].
    Scapinelli R
    Clin Ortop; 1973; 24(3):203-9. PubMed ID: 4619064
    [No Abstract]   [Full Text] [Related]  

  • 18. In situ delivery of therapeutic cytokines by genetically engineered Lactococcus lactis.
    Steidler L
    Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet; 2001; 66(3b):551, 553-6. PubMed ID: 15954652
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene transfer from engineered Lactococcus lactis strains to Enterococcus faecalis in the digestive tract of gnotobiotic mice.
    Gruzza M; Langella P; Duval-Iflah Y; Ducluzeau R
    Microb Releases; 1993 Dec; 2(3):121-5. PubMed ID: 8111532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applicability of phase I trial results in the design of phase II and III biological response modifier trials.
    Pinsky CM
    Cancer Treat Rep; 1985 Oct; 69(10):1171-3. PubMed ID: 4042095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.